Hub genes including CSF2, CTLA4, ETS1, PIK3CD, and CFTR may act as efficient biomarkers for diagnosis while CTLA4 and FGFR2 serve as promising biomarkers for the prognosis evaluation of HNSCC. Here, CSF2 is linked to head and neck squamous cell carcinoma.